Moderna (MRNA) Increasing Global Vaccine Supply

<p>Moderna: MRNA earnings report indicated $2.84 in EPS and $1.9B in revenue. The company will supply a Covid-19 booster vaccine to Switzerland. Oppenheimer's Hartaj Singh weighs in and says that they have an outperform rating on the stock with a $206 price target.</p>